|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$103,385.52 |
3.30% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$97,990.06 |
3.12% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$90,946.54 |
2.90% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$87,871.77 |
2.80% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$86,278.04 |
2.75% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$83,341.02 |
2.66% |
| Waters Corporation |
WAT |
941848103 |
184 |
$80,982.08 |
2.58% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$80,142.02 |
2.55% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$80,034.90 |
2.55% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$79,857.68 |
2.55% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$79,611.34 |
2.54% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$77,635.51 |
2.47% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$75,288.96 |
2.40% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$75,134.07 |
2.39% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$71,844.20 |
2.29% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$69,815.55 |
2.23% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$69,373.35 |
2.21% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$69,015.94 |
2.20% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$68,575.10 |
2.19% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$68,294.95 |
2.18% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$66,577.06 |
2.12% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$66,033.11 |
2.10% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$64,590.92 |
2.06% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$62,369.52 |
1.99% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$61,147.49 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$59,467.72 |
1.90% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$58,858.80 |
1.88% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$57,963.81 |
1.85% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$57,497.88 |
1.83% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,445.58 |
1.80% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$56,197.27 |
1.79% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,933.55 |
1.78% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$54,173.84 |
1.73% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$53,052.18 |
1.69% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$52,842.40 |
1.68% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,923.64 |
1.59% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$49,736.53 |
1.59% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$49,628.28 |
1.58% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$49,082.73 |
1.56% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$48,612.97 |
1.55% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$47,821.00 |
1.52% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$46,918.31 |
1.50% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$47,005.56 |
1.50% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,704.77 |
1.46% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,535.49 |
1.42% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$44,163.14 |
1.41% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,628.86 |
1.33% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$40,686.00 |
1.30% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$40,492.00 |
1.29% |
| US Dollar |
$USD |
|
12,636 |
$12,635.93 |
0.40% |
| Australian Dollar |
$AUD |
|
601 |
$418.94 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|